I'd like to get another question in first, if you don't mind.
If you can, please explain the thinking within your member companies when the FDA or the European Medicines Agency orders a drug off the market for injuring and killing patients. What is the thinking in your companies that they can still leave that drug on the market in 100 other countries, including Canada sometimes?
They have essentially been ordered to take the drug off the market, or they put up a facade that they voluntarily took it off the market because they're about to be ordered to, and they maintain this facade that the drug can be prescribed safely and they just keep it on the market until they're ordered to take it off. What is the ethical thinking in those companies?